Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CPNG
CPNG logo

CPNG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Coupang Inc (CPNG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
18.770
1 Day change
-2.14%
52 Week Range
34.080
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Coupang Inc (CPNG) is not a strong buy for a beginner, long-term investor at this moment. While the company has long-term growth potential and analysts maintain an overall positive outlook, recent financial performance, ongoing regulatory investigations, and hedge fund selling trends suggest caution. The stock is better suited for monitoring until clearer positive catalysts emerge.

Technical Analysis

The MACD histogram is positive at 0.307, indicating bullish momentum, but it is contracting. RSI is neutral at 61.244, and moving averages are converging, suggesting no strong directional trend. Key resistance is at 20.014, with support at 17.958. The stock shows a 60% chance of a small gain in the next day or week but a potential decline over the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest a moderately bullish sentiment in the options market. However, implied volatility is high (48.2%), indicating uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Named to LexisNexis' Global Innovators 100, showcasing strong innovation and patent growth.

  • Analysts maintain mostly positive ratings with price targets above the current price, reflecting long-term potential.

  • Revenue increased by 10.92% YoY in Q4 2025, indicating some growth momentum.

Neutral/Negative Catalysts

  • Regulatory investigations into fiduciary breaches and data security issues create reputational and financial risks.

  • Hedge funds are selling significantly, with a 252.50% increase in selling activity last quarter.

  • Financial performance in Q4 2025 showed a net income drop of -116.67% YoY and EPS decline of -112.50%, reflecting profitability challenges.

Financial Performance

In Q4 2025, revenue grew by 10.92% YoY to $8.835 billion. However, net income fell to -$26 million (-116.67% YoY), and EPS dropped to -0.01 (-112.50% YoY). Gross margin also declined to 28.79% (-7.93% YoY), indicating worsening profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain mostly positive ratings with multiple Overweight and Buy recommendations. Price targets range from $17 to $29, with recent adjustments reflecting cautious optimism. Analysts see long-term competitive advantages but acknowledge near-term challenges from regulatory risks and data breach fallout.

Wall Street analysts forecast CPNG stock price to rise
6 Analyst Rating
Wall Street analysts forecast CPNG stock price to rise
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 19.180
sliders
Low
22
Averages
33.83
High
40
Current: 19.180
sliders
Low
22
Averages
33.83
High
40
Barclays
NULL -> Overweight
maintain
$23 -> $24
AI Analysis
2026-03-02
Reason
Barclays
Price Target
$23 -> $24
AI Analysis
2026-03-02
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Coupang to $24 from $23 and keeps an Overweight rating on the shares post the Q4 report.
Morgan Stanley
Overweight
downgrade
$31 -> $29
2026-03-02
Reason
Morgan Stanley
Price Target
$31 -> $29
2026-03-02
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Coupang to $29 from $31 and keeps an Overweight rating on the shares. The firm, which believes the worst of the data breach is behind the company with regulatory risk dissipating and damage being finalized, sees operating metrics in Korea recovering and progress in Taiwan that "appears on track."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CPNG
Unlock Now

People Also Watch